Find the latest analyst research for MannKind Corporation Common Stock (MNKD) at Nasdaq.com. MNKD MannKind Corp. — Stock Price and Discussion | Stocktwits Real-time trade and investing ideas on MannKind Corp. MNKD from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Could MannKind Corporation Be a Millionaire-Maker Stock ... MannKind's stock isn't a compelling contrarian buy. MannKind Corporation (NASDAQ:MNKD) has lost a staggering 90% of its value. And the company now appears to be hanging on by the skin of its MNKD Stock Price, Forecast & News (MannKind) | MarketBeat 5 brokerages have issued 12-month price objectives for MannKind's stock. Their forecasts range from $2.50 to $3.00. On average, they expect MannKind's stock price to reach $2.75 in the next twelve months. This suggests a possible upside of 191.9% from the stock's …
Stock News - TD Ameritrade MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic. MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products, today announced that it is adjusting research and development resources that were reserved for its pipeline of
View detailed financial information, real-time news, videos, quotes and analysis on MannKind Corp. (NASDAQ:MNKD). Explore commentary on MannKind Corp. and hear what the experts at TheStreet are
MannKind's stock isn't a compelling contrarian buy. MannKind Corporation (NASDAQ:MNKD) has lost a staggering 90% of its value. And the company now appears to be hanging on by the skin of its MNKD Stock Price, Forecast & News (MannKind) | MarketBeat
MannKind Corporation (MNKD) Stock Sinks on ... - InvestorPlace